title: Generic drug maker wins right to sue for anti-competitive practices.
abstract: In December 2000, the Ontario Court of Appeal upheld the right of generic drug manufacturer Apotex Inc to sue three name-brand pharmaceutical companies for allegedly anti-competitive practices. Apotex's claim had been struck out by a lower court, but the appellate court overturned this judgment and allowed the suit to proceed. The facts alleged by Apotex, if eventually proved true, could support a court finding that the name-brand companies were in fact liable.
authors.forename: R
authors.initials: R
authors.lastname: Elliott
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D016568:Drugs, Generic; D004465:Economic Competition / Q000331:legislation & jurisprudence*; D006801:Humans; D009864:Ontario
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic